CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+9.39%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.36B
AUM Growth
+$1.36B
(+16%)
Cap. Flow
+$68M
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
54.47%
Holding
56
New
7
Increased
9
Reduced
9
Closed
11
Top Buys
| 1 |
LivaNova
LIVN
|
$71.2M |
| 2 |
HCA Healthcare
HCA
|
$67.6M |
| 3 |
Brookdale Senior Living
BKD
|
$41.5M |
| 4 |
SUNE
SUNation Energy, Inc. Common Stock
SUNE
|
$38.9M |
| 5 |
Tenet Healthcare
THC
|
$30.3M |
Top Sells
| 1 |
CYBX
CYBERONICS INC
CYBX
|
$60.8M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
$48.6M |
| 3 |
Cross Country Healthcare
CCRN
|
$20.3M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$20.1M |
| 5 |
HMSY
HMS Holdings Corp.
HMSY
|
$19.1M |
Sector Composition
| 1 | Healthcare | 74.48% |
| 2 | Consumer Staples | 2.91% |
| 3 | Technology | 2.87% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $118M | 7.63% | 1,800,000 -200,000 | -10% | -$13.1M |
|
|
GHDX
2
DELISTED
Genomic Health, Inc.
GHDX
| $86.5M | 5.59% | 2,458,100 +8,100 | +0.3% | +$285K |
|
|
MDCO
3
DELISTED
Medicines Co
MDCO
| $82.1M | 5.31% | 2,200,000 -300,000 | -12% | -$11.2M |
|
|
4
LivaNova
LIVN
$3.08B
| $71.2M | 4.6% | +1,200,000 | New | +$71.2M |
|
5
AstraZeneca
AZN
$248B
| $67.9M | 4.39% | 2,000,000 -500,000 | -20% | -$17M |
|
|
6
HCA Healthcare
HCA
$94.5B
| $67.6M | 4.37% | +1,000,000 | New | +$67.6M |
|
7
Viatris
VTRS
$12.3B
| $67.6M | 4.37% | 1,250,000 -250,000 | -17% | -$13.5M |
|
|
NUVA
8
DELISTED
NuVasive, Inc.
NUVA
| $59.5M | 3.85% | 1,100,000 | – | – |
|
9
Nektar Therapeutics
NKTR
$568M
| $59M | 3.81% | 3,500,000 +1,250,000 | +56% | +$21.1M |
|
10
Orthofix Medical
OFIX
$592M
| $58.8M | 3.8% | 1,500,000 | – | – |
|
11
Select Medical
SEM
$1.61B
| $53.6M | 3.46% | 4,500,000 +150,000 | +3% | +$1.79M |
|
|
12
Tenet Healthcare
THC
$16.3B
| $45.5M | 2.94% | 1,500,000 +1,000,000 | +200% | +$30.3M |
|
13
Quest Diagnostics
DGX
$20.3B
| $42.7M | 2.76% | 600,000 +381,500 | +175% | +$27.1M |
|
|
14
Brookdale Senior Living
BKD
$1.83B
| $41.5M | 2.68% | +2,250,000 | New | +$41.5M |
|
15
Masimo
MASI
$7.59B
| $41.5M | 2.68% | 1,000,000 | – | – |
|
|
UAM
16
DELISTED
Universal American Corp
UAM
| $41.1M | 2.66% | 5,875,000 | – | – |
|
|
MJN
17
DELISTED
Mead Johnson Nutrition Company
MJN
| $39.5M | 2.55% | 500,000 -100,000 | -17% | -$7.9M |
|
|
SUNE
18
SUNation Energy, Inc. Common Stock
SUNE
$5.08M
| $38.9M | 2.52% | +2,575,000 | New | +$38.9M |
|
19
Labcorp
LH
$23.1B
| $37.1M | 2.4% | 300,000 -100,000 | -25% | -$12.4M |
|
|
ARIA
20
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $33.8M | 2.18% | 5,405,235 -127,883 | -2% | -$799K |
|
|
SQNM
21
DELISTED
SEQUENOM INC NEW
SQNM
| $28.3M | 1.83% | 17,250,000 +5,500,000 | +47% | +$9.02M |
|
|
ARNA
22
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $20M | 1.29% | 10,500,000 +750,000 | +8% | +$1.43M |
|
|
NVTA
23
DELISTED
Invitae Corporation
NVTA
| $16.6M | 1.07% | 2,024,943 +1,130,929 | +127% | +$9.29M |
|
24
PTC Therapeutics
PTCT
$3.92B
| $16.2M | 1.05% | +500,000 | New | +$16.2M |
|
25
Protalix BioTherapeutics
PLX
$124M
| $13.5M | 0.88% | 13,275,000 +6,000,423 | +82% | +$6.12M |
|